Understanding Early COPD.

Area of Science:

• Pulmonology
• Respiratory Medicine
• Disease Pathogenesis

Background:

• Chronic Obstructive Pulmonary Disease (COPD) is currently defined by spirometric obstruction.
• Pathologic changes like chronic mucus hypersecretion and emphysema are recognized in at-risk individuals.
• Early identification of individuals at risk for COPD progression, prior to pulmonary function abnormality, is a clinical challenge.

Purpose of the Study:

• To explore the evolution of terminology and criteria for identifying early-stage Chronic Obstructive Pulmonary Disease (COPD).
• To discuss the limitations of previous concepts like GOLD 0 and the utility of terms such as pre-COPD and early COPD.
• To highlight the ongoing challenges in identifying at-risk populations and developing targeted therapies for early-stage disease.

Main Methods:

• Review of existing definitions and concepts for early Chronic Obstructive Pulmonary Disease (COPD).
• Analysis of the role of symptoms, physiologic, and radiographic abnormalities in risk identification.
• Discussion of patient recruitment for observational studies in early COPD.

Main Results:

• The concept of GOLD 0, based on symptoms, was abandoned as it failed to identify most individuals who progress to COPD.
• Terms like pre-COPD and early COPD have been introduced to identify individuals at risk based on symptoms or early abnormalities.
• Early COPD specifically focuses on younger individuals with early abnormalities, excluding mild late-stage disease.

Conclusions:

• Accurate identification of individuals at risk for Chronic Obstructive Pulmonary Disease (COPD) before significant lung function decline is difficult.
• Current terminology like pre-COPD and early COPD attempts to address this gap but challenges remain.
• Further research is needed to refine identification strategies and develop specific therapies for early-stage COPD.